Description
Seeking adults with Pancreatic Ductal Adenocarcinoma who have a PET scan scheduled in the next 3 weeks for treatment planning for a study of an investigational diagnostic test for metastatic disease.
Overview
Participants in this study will have a PET scan using an investigational contrast agent. This PET scan will be in addition to the PET scan they will get for usual care. There will be up to 4 study visits over 3 months.
What we're hoping for
We are studying whether an investigational diagnostic agent added to a PET scan is able to detect metastatic disease for people with pancreatic ductal adenocarcinoma.
Additional Information
ClinicalTrials.gov Identifier: NCT07217717